That kind of stuff is intolerable when we're competing with China where they're doing phase ones in four weeks. With Australia, that's doing phase ones in six weeks.
“That kind of stuff is intolerable when we're competing with, China where they're doing phase ones in four weeks.”
That kind of stuff is intolerable when we're competing with, China where they're doing phase ones in four weeks. With, Australia, that's doing phase ones in six weeks. And so we need to, have more centralized IRBs and we need to streamline the hospital contracting. Because right now, if you wanna do a trial, each hospital wants to negotiate their margin of what they want and ensure they have to customize the contract because every study is different, has different requirements and resources that are needed. But you go to Australia and they say, sure, sign here on the dotted line. You have access to these 14 hospitals or so. And so, we have got to have more centralized contracting and a centralized
Why this clip
Direct competitive framing with specific timelines (4 weeks vs 6 weeks) that highlight US inefficiency. The word 'intolerable' adds emotional weight while contrasting US bureaucracy with international competitors. Perfect soundbite format.
What they said next
We looked at 20 other developed countries and found that not only are we the international outlier in how high the number of doses we recommend is, but that there's a consensus of a group of core essential vaccines.
52:40 - 41s · Business Mechanics
More from this episode
From the blog
Want clips like this for your podcast?
We find your top 5-8 clips, write the hooks, and deliver ready-to-post content. First 2 episodes are free.
Get 2 Episodes Clipped Free